Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryoport (CYRX) Cash from Financing Activities (2016 - 2025)

Cryoport (CYRX) has disclosed Cash from Financing Activities for 14 consecutive years, with -$2.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities fell 207.01% to -$2.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$21.1 million, a 86.95% increase, with the full-year FY2025 number at -$21.1 million, up 86.95% from a year prior.
  • Cash from Financing Activities was -$2.2 million for Q4 2025 at Cryoport, up from -$2.9 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $288.6 million in Q4 2021 to a low of -$155.3 million in Q3 2024.
  • A 5-year average of $15.9 million and a median of -$324000.0 in 2022 define the central range for Cash from Financing Activities.
  • Peak YoY movement for Cash from Financing Activities: surged 9376.01% in 2021, then crashed 5322.88% in 2023.
  • Cryoport's Cash from Financing Activities stood at $288.6 million in 2021, then tumbled by 101.84% to -$5.3 million in 2022, then skyrocketed by 97.63% to -$126000.0 in 2023, then surged by 1696.83% to $2.0 million in 2024, then tumbled by 207.01% to -$2.2 million in 2025.
  • Per Business Quant, the three most recent readings for CYRX's Cash from Financing Activities are -$2.2 million (Q4 2025), -$2.9 million (Q3 2025), and -$15.9 million (Q2 2025).